Epperly Melissa B, 4

What Happened
Melissa B. Epperly, a director of Roivant Sciences Ltd. (ROIV), was granted 815 common shares under the company's Non-Employee Director Compensation Plan on 2026-01-20 (reported as an acquisition at $0.00). To satisfy tax withholding on the vested award, 54 of those shares were net-settled/disposed at $22.98 per share, resulting in $1,241 withheld.

Key Details

• Transaction dates: 2026-01-20 (grant and tax withholding); Form 4 filed 2026-01-22 (timely).
• Grant: 815 shares acquired (code A) at reported $0.00 (award fully vested as of grant date).
• Tax withholding: 54 shares withheld/disposed (code F) at $22.98 per share = $1,241.
• Shares owned after transaction: not specified in this filing.
• Footnotes: F1—award was fully vested on grant date; F2—54 shares were net-settled by the issuer to satisfy tax withholding.
• Filing timeliness: filed within two days of the transaction (appears timely).

Context
This was a compensation award to a non-employee director and a routine net settlement to cover taxes (not an open-market purchase or directional sale). Awards and tax-withholding dispositions are common for director pay and do not by themselves indicate a buy/sell signal about the company's prospects. Transaction codes: A = award/grant; F = tax withholding/net settlement.